1. Home
  2. Labeler Index
  3. Lonza Biologics, Inc.
  4. 67643-7007
  5. NDC Package Code: 67643-7007-1 Tocilizumab

NDC Package 67643-7007-1 Tocilizumab

Liquid - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67643-7007-1
Package Description:
2000 mL in 1 BOTTLE
Product Code:
67643-7007
Non-Proprietary Name:
Tocilizumab
Substance Name:
Tocilizumab
Usage Information:
This medication is used alone or with other medications to treat moderate to severe rheumatoid arthritis in adults. It is also used to treat rheumatoid arthritis in children (such as systemic juvenile idiopathic arthritis-SJIA, polyarticular juvenile idiopathic arthritis-PJIA). It helps to reduce pain and swelling due to rheumatoid arthritis. Tocilizumab may also be used to treat a reaction (Cytokine Release Syndrome-CRS) caused by certain cancer treatments. Tocilizumab belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. It works by blocking IL-6, a substance made by the body that causes swelling (inflammation).
11-Digit NDC Billing Format:
67643700701
Product Type:
Drug For Further Processing
Labeler Name:
Lonza Biologics, Inc.
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Active Ingredient(s):
TOCILIZUMAB 60 mg/mL
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
01-08-2010
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 67643-7007-1?

The NDC Packaged Code 67643-7007-1 is assigned to an UNFINISHED drug package of 2000 ml in 1 bottle of Tocilizumab, drug for further processing labeled by Lonza Biologics, Inc.. The product's dosage form is liquid and is administered via form.

Is NDC 67643-7007 included in the NDC Directory?

Yes, Tocilizumab is an UNFINISHED PRODUCT with code 67643-7007 that is active and included in the NDC Directory. The product was first marketed by Lonza Biologics, Inc. on January 08, 2010 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 67643-7007-1?

The 11-digit format is 67643700701. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-167643-7007-15-4-267643-7007-01